|
|
Volumn 51, Issue 1, 2010, Pages 40-46
|
|
An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the αvβ3- selective angiogenesis imaging agent 99mTc-NC100692
a
|
|
Author keywords
Angiogenesis; Breast cancer; Lung cancer; Metastases; Radionuclide imaging
|
|
Indexed keywords
ANGIOGENESIS;
BONE SCINTIGRAPHY;
BRAIN METASTASIS;
BREAST CANCER;
CANCER PATIENTS;
COMPUTED TOMOGRAPHY;
IMAGING AGENT;
INTEGRINS;
LIVER METASTASIS;
LUNG CANCER;
MALIGNANT LESION;
MEMBRANE PROTEINS;
METASTATIC LESIONS;
NEOVASCULATURE;
OXIMETRY;
POTENTIAL TOOL;
RADIONUCLIDE IMAGING;
REFERENCE STANDARD;
SAFETY MEASUREMENTS;
SAFETY PARAMETERS;
SPECT ACQUISITION;
UP PERIOD;
URINE ANALYSIS;
VITAL SIGN;
WHOLE-BODY;
BIOCHEMISTRY;
BODY FLUIDS;
BONE;
COAGULATION;
COMPUTERIZED TOMOGRAPHY;
LIVER;
MAGNETIC RESONANCE IMAGING;
PROTEINS;
RADIOISOTOPES;
RESONANCE;
PATHOLOGY;
CONTRAST MEDIUM;
CYCLOPEPTIDE;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
TECHNETIUM 99M NC 100692;
TECHNETIUM COMPLEX;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
EUROPE;
FEASIBILITY STUDY;
FEMALE;
HUMAN;
LUNG TUMOR;
MALE;
METASTASIS;
METHODOLOGY;
MIDDLE AGED;
MULTICENTER STUDY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
SCINTISCANNING;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
UNITED STATES;
ADULT;
AGED;
AGED, 80 AND OVER;
BREAST NEOPLASMS;
CONTRAST MEDIA;
EUROPE;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
ORGANOTECHNETIUM COMPOUNDS;
PEPTIDES, CYCLIC;
RADIOPHARMACEUTICALS;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
TOMOGRAPHY, X-RAY COMPUTED;
UNITED STATES;
|
|
EID: 75649102481
PISSN: 02841851
EISSN: 16000455
Source Type: Journal
DOI: 10.3109/02841850903273974 Document Type: Article |
|
Times cited : (57)
|
|
References (16)
|
